{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-006220","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2025-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.920618+00:00","generated_at":"2026-05-22T16:48:28.794873+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Iradimed Q1 record revenue $19.5M (+11% YoY); EPS $0.37 GAAP, $0.42 non-GAAP","bullets":["Record Q1 revenue of $19.5M, up 11% YoY from $17.6M; GAAP diluted EPS $0.37 (+16% YoY).","Non-GAAP diluted EPS $0.42 (+17% YoY); excludes $0.7M stock compensation net of tax.","Declared regular quarterly cash dividend of $0.17/share, payable May 30, 2025 to holders of record May 20.","Q2 2025 guidance: revenue $19.7-19.9M; GAAP EPS $0.37-0.40; non-GAAP EPS $0.41-0.44.","Reaffirms FY 2025 guidance: revenue $78-82M; GAAP EPS $1.55-1.65; non-GAAP EPS $1.71-1.81."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-006220","json":"https://secwatch.observer/filing/0001558370-25-006220.json","markdown":"https://secwatch.observer/filing/0001558370-25-006220.md","text":"https://secwatch.observer/filing/0001558370-25-006220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000155837025006220/0001558370-25-006220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000155837025006220/irmd-20250505x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T16:48:28.794873+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}